Keywords: gsk, arixtra, seretide/advair, approved, japan, uk, drug
GSK's Arixtra and Seretide/Advair approved in Japan
Article | 23 April 2007
UK drug major GlaxoSmithKline's asthma medicine Seretide/Advair Diskus (salmeterol and fluticasone proprionate combination) and its anti-thrombic Arixtra (fondaparinux sodium) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
